Are you Dr. Zheng?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 2 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105Phone+1 901-595-1145- Is this information wrong?
Summary
- Dr. Yan Zheng, MD is a board certified pathologist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee, Connecticut, and Pennsylvania. She is affiliated with St. Jude Children's Research Hospital.
Education & Training
- Beijing Medical UniversityClass of 1998
Certifications & Licensure
- TN State Medical License 2017 - 2025
- PA State Medical License 2015 - 2022
- CT State Medical License 2016 - 2020
- NY State Medical License 2008 - 2017
- OH State Medical License 2013 - 2016
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- Optimization of single-needle red cell exchange in patients with sickle cell disease.Lilora Kearney, Regina Bosnick, Haley Phillips, Amanda Ghio, Dierdre Cullen, Lori Sweat, Yan Zheng> ;Journal of Clinical Apheresis. 2024 Jun 1
- RH genotypes and red cell alloimmunization rates in chronically transfused patients with sickle cell disease: A multisite study in the USA.Narek Israelyan, Sunitha Vege, David F Friedman, Zhe Zhang, Stacey Uter, Ross M Fasano, Marianne Yee, Shannon Kelly, Jane S Hankins, Yan Zheng, Connie M Westhoff, Stel...> ;Transfusion. 2024 Mar 1
- 2 citationsProinflammatory state promotes red blood cell alloimmunization in pediatric patients with sickle cell disease.Yan Zheng, Jeffrey M Gossett, Pei-Lin Chen, Martha Barton, Missy Ryan, Jing Yu, Guolian Kang, Jane S Hankins, Stella T Chou> ;Blood Advances. 2023 Sep 12
- Join now to see all
Press Mentions
- ILT4 Inhibition Prevents TAM- and Dysfunctional T Cell-Mediated Immunosuppression and Enhances the Efficacy of Anti-PD-L1 Therapy in NSCLC with EGFR ActivationJanuary 19th, 2021
- LINC00173.v1 Promotes Angiogenesis and Progression of Lung Squamous Cell Carcinoma by Sponging miR-511-5p to Regulate VEGFA ExpressionMay 30th, 2020
- AABBs National Blood Foundation Announces 2019 Early-Career Grant RecipientsJuly 23rd, 2019
- Join now to see all
Hospital Affiliations
- St. Jude Children's Research HospitalMemphis, Tennessee